Press-release for stocks published on previous years in the professional, scientific, and technical services sector

Prices are updated after-hours

published : Previous years sector : Professional, scientific, and technical services

save search

Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Published: 2024-04-24 (Just crawled : 14:00) - biospace.com/
SNPX | $4.55 -0.44% 8.6K

Professional, Scientific, and T...

| 0.0% | O: -0.44% H: 0.0% C: 0.0%
nasdaq for

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2024-04-24 (Just crawled : 14:00) - globenewswire.com
HOWL | $6.65 3.26% 17K

Professional, Scientific, and T...

| 0.0% | O: 2.02% H: 0.0% C: 0.0%
wtx-124 presentation for meeting therapeutics

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
Published: 2024-04-24 (Crawled : 13:00) - globenewswire.com
GANX | $3.31 -2.36% 74K

Professional, Scientific, and T...

| 0.0% | O: -0.29% H: 0.0% C: 0.0%
gt-0228 disease positive for parkinson’s trial therapeutics therapy results

SensaSure Technologies and Verde Bio Holdings Provide Update on Pending Merger
Published: 2024-04-24 (Crawled : 12:00) - globenewswire.com
BR | $195.64 -0.14% 19K

Commercial Services

| 0.36% | O: 0.15% H: 0.0% C: 0.0%
update

BriaCell Announces Oral and Poster Presentations at ASCO 2024
Published: 2024-04-24 (Crawled : 12:00) - globenewswire.com
BCTX | $2.2 8.6K

Professional, Scientific, and T...

| Email alert Add to watchlist
asco

DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-04-24 (Crawled : 08:00) - prnewswire.com
DOCS | $24.56 -0.08% 190K

Professional, Scientific, and T...

| -0.36% | O: 0.1% H: 0.0% C: 0.0%
PERI | $11.58 2.03% 160K

Technology Services

| 3.28% | O: 6.46% H: 0.0% C: 0.0%

Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DH | $7.25 -0.27% 300K

Professional, Scientific, and T...

| Email alert Add to watchlist
first conference financial results

Seer to Report First Quarter 2024 Financial Results on May 8, 2024
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
SEER | $1.785 -1.38% 47K

Professional, Scientific, and T...

| Email alert Add to watchlist
first report financial results

Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
Published: 2024-04-23 (Crawled : 20:00) - globenewswire.com
DAWN S | $15.545 -6.58% 1.4M

Professional, Scientific, and T...

| Email alert Add to watchlist
day fda approval tumor for

Acurx Pharmaceuticals, Inc. to Discuss First Quarter 2024 Financial Results on May 15, 2024 Conference Call and Provide Business Update
Published: 2024-04-23 (Crawled : 18:00) - biospace.com/
ACXP | $2.04 4.1K

Professional, Scientific, and T...

| 3.03% | O: -1.01% H: 4.59% C: 4.08%
first conference business update financial results

iCoreConnect Inc. Announces New State Endorsement of Seven Solutions From the Tennessee Dental Association
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
ICCT | $1.1 5.3K

Professional, Scientific, and T...

| Email alert Add to watchlist
endorsement association state dental solutions

GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
Published: 2024-04-23 (Crawled : 12:30) - globenewswire.com
WGS | $12.0 13K

Professional, Scientific, and T...

| 22.82% | O: 4.71% H: 22.87% C: 17.3%
partnership rare disease health

Werewolf Therapeutics Presents First Preclinical Data Highlighting IL-10 INDUKINE Molecules as a Potential Therapy for Inflammatory Bowel Disease (IBD) at AAI Annual Meeting
Published: 2024-04-23 (Crawled : 12:00) - globenewswire.com
HOWL | $6.65 3.26% 17K

Professional, Scientific, and T...

| 7.33% | O: 2.17% H: 5.06% C: 5.06%
il-10 first disease preclinical for meeting therapeutics potential therapy

Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
IPSC | $2.93 -6.39% 24K

Professional, Scientific, and T...

| 2.29% | O: 0.98% H: 15.21% C: 1.29%
genetic cell therapeutics therapy

First Advantage Releases 2024 Global Trends Report
Published: 2024-04-23 (Crawled : 10:00) - globenewswire.com
FA | $16.32 -0.55% 73K

Professional, Scientific, and T...

| 7.25% | O: 3.07% H: 5.77% C: 4.06%
first report advantage global trends

TScan Therapeutics Announces Upcoming Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
Published: 2024-04-22 (Crawled : 21:00) - globenewswire.com
TCRX | News | $7.235 -0.34% 6.3K

Professional, Scientific, and T...

| 1.97% | O: 1.4% H: 4.57% C: 0.55%
cell meeting therapeutics therapy

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024
Published: 2024-04-22 (Crawled : 20:00) - globenewswire.com
AKYA | News | $3.81 530

Professional, Scientific, and T...